Circulation. 1996;94:1781-1785
(Circulation. 1996;94:1781-1785.)
© 1996 American Heart Association, Inc.
Cardiologist Adapts to Healthcare Change for the Year 2000
The Herrick Lecture
Richard Gorlin, MD
The Dr George Baehr Professor of Clinical Medicine and Senior Vice President, the Mount Sinai Medical Center, and Medical Director, the Mount Sinai Health System, New York, NY.
Correspondence to Richard Gorlin, MD, Mount Sinai Medical Center, Box 1018, 1 Gustave L. Levy Pl, New York, NY 10029.
Key Words: cost-benefit analysis health maintenance organizations healthcare planning
 |
Introduction
|
|---|
Cardiology as a medical discipline has reached a critical stretch
of white water unlike any it has navigated over the past 40
years. The changes our specialty now faces have been brought
about not, as in the past, by conceptual or technical advances
but rather by cost barriers that will govern every aspect of
our work, including education, research, and clinical practice,
for as long as anyone can predict.
 |
History: How Did We Get Here From There?
|
|---|
A little more than 40 years ago, when I first entered Dr. Lewis
Dexter's laboratory as a cardiology fellow at Harvard Medical
School and the Peter Bent Brigham Hospital, cardiac catheterization
had been in use for only about 3 or 4 years. It dominated our
work in unraveling the questions of circulatory physiology and
biochemistry. Shortly thereafter, we began to focus on how the
heart functions both as a muscle and as a pump. That was an
era of both technological innovation and conceptual advancement
best exemplified by new, accurate radiographic imaging techniques.
These methods augmented and complemented the physiological pressure-flow
measurements and revolutionized the field. They showed us the
cardiac chambers and the coronary and other arteries in ways
never before possible, thus refining the concept and role of
cardiovascular dimension and volume in heart function. All of
this culminated in the 1980s with the advent of focused intervention
and remarkably effective surgery. Molecular biology, which now
dominates academic cardiology, was beginning to find its place
in the field. We now have unique drugs for clinical care, and
large clinical
. . . [Full Text of this Article]